Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement
Completed · Not applicable
Conditions studied: Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health
In brief
Omega-3 index is used as a proxy for an adequate intake of fish unsaturated fats in the diet. However, omega-3 supplements have not consistently shown the health benefits of eating fresh fish. This study will assess the change in omega-3 index and impact on markers of cardiometabolic health with two different supplements: a whole, unprocessed salmon oil and a standard, processed, concentrated oemga-3 oil. The markers to be studies included impact on inflammation and oxidative stress, cholesterol and markers of risk of diabetes. Change in sleep metrics will also be assessed.
Key facts
- Study ID
- NCT06802068
- Run by
- Hofseth Biocare ASA
- People needed
- 96
- Starts
- 2025-02-18
- Expected to finish
- 2026-01-05
- Last updated by the study team
- 2026-02-23
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy, non-pregnant adults; 40-80 years of age; stable body weight prior 3 months
You may not qualify if…
- Fish or seafood allergies; Pregnant; already consuming fish oil supplementation; malabsorption states; malignancy in remission for less than 12 months; diabetic
Where it is running
- Alethios — Menlo Park, California, United States
- Alethios, Inc. — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.